Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,604.70
(
-0.30%
)
US TECH 100
23,594.40
(
-0.85%
)
Dow Jones
46,041.29
(
-0.40%
)
Brent Oil
104.32
(
-2.13%
)
Bitcoin
69,931.99
(
-1.84%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Biowatch post# 63170

Thursday, 06/12/2008 7:38:17 PM

Thursday, June 12, 2008 7:38:17 PM

Post# of 257259
Re: IMM program in HCV

>The prototype compound belongs to an expanding class of compounds that has previously demonstrated activity against a related surrogate virus, bovine viral diarrhea virus (BVDV).<

This is the first I’ve heard of this approach to HCV drug discovery.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now